Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yaz Flex versus conventional Yaz for primary dysmenorrhea
2006-004899-13Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of YAZFlex and ethinyl estradiol + drospirenone in primary dysmenorrhea (PD) (2 arms), sponsored by Bayer. Primary endpoint: Primary efficacy variables. Started Sep 2007; status: completed.
02
Drugs
YAZFlexethinyl estradiol + drospirenone
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2006-004899-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004899-13.